Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy Assembly.

Autor: Alkhudair N; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Howaidi J; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia., Alnuhait M; Department of Clinical Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia., Alshamrani M; Pharmaceutical Care Services, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia., Khan M; Pharmaceutical Care Services, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia., Alharbi A; Pharmaceutical Care Services, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia., Alnajjar F; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia., Bajnaid E; Pharmaceutical Care Services Administration, King Abdullah Medical City, Makkah, Saudi Arabia., Almodaheem H; Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia., Alhowimel M; Unified Procurement, National Unified Procurement Company, Riyadh, Saudi Arabia., Alzahrani A; Medical Oncology Department, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia., Khardaly A; Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia., Alnahedh M; Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia., Elsoudi H; Clinical Pharmacy Department, Pharmaceutical Care Services Administration, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Alabdulkareem H; Drug Policy and Economic Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; Doctoral School of Applied Informatics and Applied Mathematics, Óbuda University, Budapest, Hungary., Alrashidan A; Corporate pharmaceutical planning, logistic & contracts management, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alzahrani M; Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Alrajhi A; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia.; Department of Pharmacy Practice, College of Pharmacy, AlFaisal University, Riyadh, Saudi Arabia.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Feb 20, pp. 10781552241232697. Date of Electronic Publication: 2024 Feb 20.

Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals.

Autor: Alamer A; Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.; Center for Health Outcomes & Pharmacoeconomics Research, University of Arizona, Tucson, AZ, USA., Almutairi AR; Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Halloush S; Department of Clinical Pharmacy & Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan., Al-Jedai A; Ministry of Health, Deputyship of Therapeutic Affairs, Riyadh, Saudi Arabia.; College of Pharmacy, Al-Faisal University, Riyadh, Saudi Arabia., Alrashed A; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia., AlFaifi M; King Fahad Medical City, Riyadh, Saudi Arabia., Mohzari Y; King Fahad Medical City, Riyadh, Saudi Arabia., Almutairi M; Department of Pharmacy Practice, College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia., AlHassar F; Department of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Howaidi J; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia., Almutairi W; Department of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia., Abraham I; Center for Health Outcomes & Pharmacoeconomics Research, University of Arizona, Tucson, AZ, USA., Alkhatib N; Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.; PI pharma intelligence, Amman, Jordan.

Publikováno v: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2023 Apr; Vol. 31 (4), pp. 510-516. Date of Electronic Publication: 2023 Feb 15.

Use of Thrombopoietin Receptor Agonists in Pregnancy: A Review of the Literature.

Autor: Howaidi J; Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia., AlRajhi AM; Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia., Howaidi A; College of Medicine, Imam Muhammad Ibn Saud Islamic University, Riyadh, Saudi Arabia., AlNajjar FH; Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia., Tailor IK; Comphrensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Publikováno v: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2022 Mar 01; Vol. 15 (1), pp. 1-6. Date of Electronic Publication: 2022 Mar 01.

Truncating mutations in YIF1B cause a progressive encephalopathy with various degrees of mixed movement disorder, microcephaly, and epilepsy.

Autor: AlMuhaizea M; Department of Neurosciences, King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia.; College of Medicine, AlFaisal University, Riyadh, Saudi Arabia., AlMass R; Department of Genetics, KFSHRC, Riyadh, Saudi Arabia., AlHargan A; Department of Genetics, KFSHRC, Riyadh, Saudi Arabia., AlBader A; Department of Genetics, KFSHRC, Riyadh, Saudi Arabia., Medico Salsench E; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Howaidi J; Department of Genetics, KFSHRC, Riyadh, Saudi Arabia., Ihinger J; University of Minnesota Medical Center, Minneapolis, MN, 55455, USA., Karachunski P; Department of Neurology, University of Minnesota, Minneapolis, MN, 55455, USA., Begtrup A; GeneDx, Gaithersburg, MD, 20877, USA., Segura Castell M; CENTOGENE AG, Am Strande 7, 18055, Rostock, Germany., Bauer P; CENTOGENE AG, Am Strande 7, 18055, Rostock, Germany., Bertoli-Avella A; CENTOGENE AG, Am Strande 7, 18055, Rostock, Germany., Kaya IH; College of Medicine, AlFaisal University, Riyadh, Saudi Arabia., AlSufayan J; Department of Genetics, KFSHRC, Riyadh, Saudi Arabia., AlQuait L; Department of Genetics, KFSHRC, Riyadh, Saudi Arabia., Chedrawi A; Department of Neurosciences, King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia., Arold ST; Division of Biological and Environmental Sciences and Engineering (BESE), Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi Arabia.; Centre de Biochimie Structurale, CNRS, INSERM, Université de Montpellier, 34090, Montpellier, France., Colak D; Department of Biostatistics, Epidemiology and Scientific Computing, KFSHRC, Riyadh, Saudi Arabia., Barakat TS; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands. t.barakat@erasmusmc.nl., Kaya N; Department of Genetics, KFSHRC, Riyadh, Saudi Arabia. nkaya@kfshrc.edu.sa.

Publikováno v: Acta neuropathologica [Acta Neuropathol] 2020 Apr; Vol. 139 (4), pp. 791-794. Date of Electronic Publication: 2020 Jan 31.

A solvent-free HPLC method for the simultaneous determination of Favipiravir and its hydrolytic degradation product.

Autor: Sharaf, Yasmine Ahmed¹ (AUTHOR), Abd El-Fattah, Mai H.² (AUTHOR) mai.hisham@must.edu.eg, El-Sayed, Heba M.¹ (AUTHOR), Hassan, Said A.^2,3 (AUTHOR)

Publikováno v: Scientific Reports. 10/28/2023, Vol. 13 Issue 1, p1-10. 10p.